US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Cleo Diagnostics Ltd (COV) 銘柄情報

Cleo Diagnostics Ltd (COV)

0.51

0.00

(0.00%)

終了 6月12日 3:00PM

Cleo Diagnostics Ltd (COV) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

0.51

( - )

買値

0.51

売値

0.52

出来高

16,613

0.51 日の範囲 0.525

0.335 52 週間の範囲 0.90

時価総額

前日終値

0.51

始値

0.525

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 169,467

発行済株式数

136,862,085

配当利回り

PER

-16.42

1 株当たり利益 (EPS)

-0.03

歳入

2.56M

純利益

-4.03M

Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determi... Cleo Diagnostics Ltd, a biotechnology company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia. The company offers CleoDX pre-surgical triage tests which measures a combination of five biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral. It also focuses on developing and testing intellectual property, testing the IP, and securing patents. Cleo Diagnostics Ltd was incorporated in 2021 and is based in Melbourne, Australia. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.cleodx.com

本社

Melbourne, Australia

設立

2026

Cleo Diagnostics Ltd is listed in the sector of the オーストラリア証券取引所 with ticker COV. The last closing price for Cleo Diagnostics was AUD0.51. Over the last year, Cleo Diagnostics shares have traded in a share price range of AUD 0.335 to AUD 0.90.

Cleo Diagnostics currently has 136,862,085 shares in issue. The market capitalisation of Cleo Diagnostics is AUD69.80 million. Cleo Diagnostics has a price to earnings ratio (PE ratio) of -16.42.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.02	-3.77358490566	0.53	0.55	0.49	114879	0.52224386	DE
4	-0.15	-22.7272727273	0.66	0.7	0.49	156237	0.60039407	DE
12	0.03	6.25	0.48	0.75	0.465	164646	0.59419814	DE
26	-0.14	-21.5384615385	0.65	0.9	0.4575	245677	0.62918399	DE
52	0.155	43.661971831	0.355	0.9	0.335	210163	0.55526542	DE
156	0.28	121.739130435	0.23	0.9	0.14	167983	0.43284105	DE
260	0.28	121.739130435	0.23	0.9	0.14	167983	0.43284105	DE

COV - Frequently Asked Questions (FAQ)

What is the current Cleo Diagnostics Ltd share price?

The current share price of Cleo Diagnostics Ltd is AUD 0.51

How many Cleo Diagnostics Ltd shares are in issue?

Cleo Diagnostics Ltd has 136,862,085 shares in issue

What is the market cap of Cleo Diagnostics Ltd?

The market capitalisation of Cleo Diagnostics Ltd is AUD 69.8M

What is the 1 year trading range for Cleo Diagnostics Ltd share price?

Cleo Diagnostics Ltd has traded in the range of AUD 0.335 to AUD 0.90 during the past year

What is the PE ratio of Cleo Diagnostics Ltd?

The price to earnings ratio of Cleo Diagnostics Ltd is -16.42

What is the cash to sales ratio of Cleo Diagnostics Ltd?

The cash to sales ratio of Cleo Diagnostics Ltd is 27.51

What is the registered address of Cleo Diagnostics Ltd?

The registered address for Cleo Diagnostics Ltd is 480 Collins Street, Melbourne, Victoria, 3000

What is the Cleo Diagnostics Ltd website address?

The website address for Cleo Diagnostics Ltd is www.cleodx.com

just Scottie

just Scottie 2分前

Same! The whole private equity business man thesis really got me good.

imanjen13

imanjen13 2分前

Hopefully Elite will make an announcement to clarify the settlement of the patent dispute involving Oxy. The key here may be that Elite's Oxy patent # 217939 has ADT properties that make it safer and more desirable for patients.
The agreement also follows the old Shakesperean adage that the

Monksdream

Monksdream 2分前

DSY, there it goes

hnbadger1

hnbadger1 3分前

From Chat gpgt- Based on the information available so far, yes, blarcamesine is still slated to be part of the European ACCESS-AD program, despite the leadership changes at Anavex. The ACCESS-AD consortium selected blarcamesine as one of the therapies to be evaluated in its five-year European Commis

hnbadger1

hnbadger1 3分前

From Chat gpgt- Based on the information available so far, yes, blarcamesine is still slated to be part of the European ACCESS-AD program, despite the leadership changes at Anavex. The ACCESS-AD consortium selected blarcamesine as one of the therapies to be evaluated in its five-year European Commis

TheKid5

TheKid5 6分前

IOS just auto updated to 36

Curios George

Curios George 6分前

No point in commenting. Until we know who the incoming company is, it’s all speculation. Buying into a shell is high risk for high reward.

I stand by my DD but i also cannot knock someone else on here for having a different opinion Because once again, it’s all speculation.

Monksdream

Monksdream 11分前

About

Big Tree Cloud Holdings Ltd. engages in providing personal care products through its subsidiaries. Its products include sanitary napkins, sanitary pants, and panty liners. The company was founded by Wen Quan Zhu in 2020 and is headquartered in Shenzhen, China. The listed

CA Market News

CA Market News 11分前

Clear Blue Technologies Provides Third Bi-Weekly MCTO Default Status ReportJune 12, 2026 7:00 AM
NewsfileToronto, Ontario--(Newsfile Co

CA Market News

CA Market News 11分前

WELL Health Provides a Corporate Update on Circle MedicalJune 12, 2026 7:00 AM
NewsfileWELL Health is providing a corporate update

CA Market News

CA Market News 11分前

Silver Elephant to Acquire High-Grade Robinson-Lasher Zinc-Germanium-Gallium Project in Kentucky, 90 Miles from Proposed US$7.4 Billion Korea Zinc Smelter in TennesseeJune 12, 2026 7:00 AM
Newsfile

CA Market News

CA Market News 11分前

Aurania Shareholders Approve All Resolutions at Annual MeetingJune 12, 2026 7:00 AM
NewsfileToronto, Ontario--(Newsfile Corp. - June 12

CA Market News

CA Market News 11分前

Steppe Gold Announces Settlement Agreement with Triple FlagJune 12, 2026 7:00 AM
NewsfileUlaanbaatar, Mongolia--(Newsfile Corp. - June

US Market News

US Market News 12分前

Sharon AI Announces Six Year Strategic Compute Collaboration with NVIDIAJune 12, 2026 7:20 AM
Business Wire NVIDIA and Sharon AI to deploy 72MW AI factory and up to 40,000 Grace Blackwell GB300 GPUs in Australia Today, SharonAI Holdings Inc. (NASDAQ:SHA

fricassee

fricassee 12分前

r/LQMT
•
10h ago
DMN_LQMT
\Apple-Liquidmetal: Why The Skeptic's Case May Be Wrong

https://www.reddit.com/r/LQMT/comments/1u3he0l/appleliquidmetal_why_the_skeptics_case_may_be/?%24deep_link=true&correlation_id=840acafe-c2ae-46df-a209-f2d6dac5199b&post_fullna

US Market News

US Market News 12分前

Natural Grocers® Celebrates Arkansas Day with a Special Gift and Savings June 15-17, 2026June 12, 2026 7:22 AM
PR Newswire (US) class="legendSpanClass"LAKEWOOD, Colo., class="legendSpanClass"June 12, 2026 /PRNewswire/ -- Natural Grocers®

Golden Cross

Golden Cross 12分前

$RITR Adding more here!

deepdj011

deepdj011 13分前

https://www.sharedeals.de/micron-aktie-1-500-us-sind-moeglich/

getmoreshares

getmoreshares 14分前

🌐UNCHANGED OUTSTANDING SHARES 6/11/26
Held at DTC 7,993,313,019 6/11/2026

Outstanding Shares 10,511,001,446 04/08/2026 (498M increase)
Restricted 2,517,513,262 04/08/2026
Unrestricted 7,993,488,184 04/08/2026(498M increase)
Held at DTC 7,993,313,019

Golden Cross

Golden Cross 14分前

$RITR Adding more here!

Bobsemptypockets

Bobsemptypockets 15分前

I have the same information everybody else has they just signed an OU to buy 51% of Ibersun and they clearly have some sort of involvement with Bloom energy so my opinion, they’re headed toward more of a data type company than just a special purpose land aggregator

EternalPatience

EternalPatience 16分前

Looks like Iran treaty is the birthday gift. Onto July 4th...

Jake731

Jake731 16分前

I’m still on 1. 3. 35
This does look better than what we’ve seen over the past year.

getmoreshares

getmoreshares 17分前

🌐Outstanding Shares 7,536,382,467 06/11/2026
Restricted 3,371,330,719 06/11/2026
Unrestricted 4,165,051,748 06/11/2026
Held at DTC 3,862,551,632 06/11/2026 (100m increase)

Outstanding Shares 7,536,382,467 06/09/2026 (50m increase)
Restricted 3,371,3

Cleo Diagnostics

UBS CMCI exAgriculture S...

MSCI USA Health Care UCI...

Panacos Pharmaceuticals (EM)

Waverley Pharma

INTESA SANPAOLO

Turmalina Metals

Romania Tf 3,375% Fb38 Eur

Spree Acquisition Corpor... (EM)

Global Payments

iNav Db x trackers MSCI ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。